Boston Scientific Corp (NYSE:BSX)
| 54.93 Delayed Data As of Nov 28 |  -0.76 / -1.36%Today’s Change | 43.62 Today|||52-Week Range 55.83 | +18.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 319.0M | 439.0M | 991.0M | 801.0M | |
| Short Term Investment Cash | -268.0M | -123.0M | 530.0M | -187.0M | ||
| Cash & Short Term Investments | 319.0M | 439.0M | 991.0M | 801.0M | ||
| Receivables | Receivables | 1.3B | 1.5B | 1.5B | 1.6B | |
| Inventories | Inventories | 1.0B | 955.0M | 1.1B | 1.2B | |
| Current Assets | Prepaid Expenses | -- | 58.0M | 66.0M | 161.0M | |
| Other Current Assets | 861.0M | 315.0M | 139.0M | 266.0M | ||
| Current Assets | 3.5B | 3.2B | 3.8B | 4.0B | ||
| Total Assets | Property, Plant and Equipment - Gross | 4.1B | 4.4B | 4.6B | 4.7B | |
| Depreciation | -2.6B | -2.7B | -2.9B | -3.0B | ||
| Intangible Assets | 12.7B | 12.6B | 12.8B | 14.3B | ||
| Other Assets | 13.1B | 13.1B | 13.1B | 14.7B | ||
| Total Assets | 18.1B | 18.1B | 19.0B | 21.0B | ||
| Liabilities | Accounts Payable | 209.0M | 447.0M | 530.0M | 349.0M | |
| Short Term Debt | 3.0M | 64.0M | 1.8B | 2.3B | ||
| Accrued Expenses | 693.0M | 615.0M | 653.0M | 766.0M | ||
| Other Current Liabilities | 1.7B | 2.5B | 2.7B | 2.0B | ||
| Other Liabilities | 2.4B | 3.6B | 5.7B | 5.3B | ||
| Total Liabilities | Long Term Debt | 5.7B | 5.4B | 3.8B | 4.8B | |
| Deferred Taxes | -695.0M | -62.0M | -103.0M | -241.0M | ||
| Other Liabilities | 1.7B | 1.2B | 1.8B | 1.5B | ||
| Total Liabilities | 11.8B | 11.4B | 12.0B | 12.3B | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 6.3B | 6.7B | 7.0B | 8.7B | ||
| Total Shareholder Equity | 6.3B | 6.7B | 7.0B | 8.7B | ||
| Share Information | Common Shares Outstanding | 1.3B | 1.4B | 1.4B | 1.4B | |
| Addtl. Info. | No data currently available for this section. | |||||
